NJ Bio is currently executing a major new program for an existing innovator customer with multiple ADC candidates in their pipeline
The Q-Switched Nd:YAG system is suitable for all skin types and offers versatility in treating dermal and epidermal pigmentation
The average baseline SALT score was 83.8, indicating about 16% scalp hair coverage
Treatment with the selective NaV1.8 pain signal inhibitor VX-993 after bunionectomy surgery did not meet the primary endpoint
Innovative plate-based internalization reagents designed to deliver accurate, high-throughput, and scalable insights for GPCR and ADC research
he new version features a streamlined sample-to-analysis workflow, built-in HRD detection, faster turnaround, and lower tissue requirements
The expanded partnership includes cGMP manufacturing, technology transfer for both drug substance and product
India Formulation sales accounted for 34.2% of total consolidated sales for the quarter
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
